External radiotherapy for prostatic cancers

R. de Crevoisier, S. Supiot, G. Créhange, P. Pommier, I. Latorzeff, O. Chapet, D. Pasquier, P. Blanchard, U. Schick, V. Marchesi, P. Sargos, C. Hennequin

    Research output: Contribution to journalArticlepeer-review

    10 Citations (Scopus)

    Abstract

    We present the update of the recommendations of the French society of oncological radiotherapy on external radiotherapy of prostate cancer. External radiotherapy is intended for all localized prostate cancers, and more recently for oligometastatic prostate cancers. The irradiation techniques are detailed. Intensity-modulated radiotherapy combined with prostate image-guided radiotherapy is the recommended technique. A total dose of 74 to 80 Gy is recommended in case of standard fractionation (2 Gy per fraction). Moderate hypofractionation (total dose of 60 Gy at a rate of 3 Gy per fraction over 4 weeks) in the prostate has become a standard of therapy. Simultaneous integrated boost techniques can be used to treat lymph node areas. Extreme hypofractionation (35 to 40 Gy in five fractions) using stereotactic body radiotherapy can be considered a therapeutic option to treat exclusively the prostate. The postoperative irradiation technique, indicated mainly in case of biological recurrence and lymph node involvement, is detailed.

    Translated title of the contributionRadiothérapie externe des cancers prostatiques
    Original languageEnglish
    Pages (from-to)329-343
    Number of pages15
    JournalCancer/Radiotherapie
    Volume26
    Issue number1-2
    DOIs
    Publication statusPublished - 1 Feb 2022

    Keywords

    • French society for radiation oncology
    • Guidelines
    • Prostate cancer
    • Radiation therapy

    Cite this